S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NYSE:VAPO

Vapotherm Stock Forecast, Price & News

$21.00
0.00 (0.00%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.84
$21.58
50-Day Range
$19.70
$27.63
52-Week Range
$16.64
$38.46
Volume
97,028 shs
Average Volume
245,940 shs
Market Capitalization
$547.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-1.34
30 days | 90 days | 365 days | Advanced Chart
Receive VAPO News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.


Vapotherm logo

About Vapotherm

Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. Its products include Precision Flow, Precision Flow Heliox, Oxygen Assist Module, Nitric Oxidie Disposable Patient Circuit, Tracheostomy Adapter, and Aerogen Adapter. The company was founded by William F. Niland, Jun Cortez, and William Cirksena in 1998 and is headquartered in Exeter, NH.

Headlines

Vapotherm (NYSE:VAPO) Shares Gap Up to $19.70
November 22, 2021 |  americanbankingnews.com
Vapotherm (NYSE:VAPO) Shares Up 6.6%
November 19, 2021 |  americanbankingnews.com
Bullish insiders bet US$5.3m on Vapotherm, Inc. (NYSE:VAPO)
November 18, 2021 |  finance.yahoo.com
Vapotherm, Inc. (NYSE:VAPO) SVP Gregoire Ramade Sells 2,000 Shares
November 5, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
401
Year Founded
N/A

Sales & Book Value

Annual Sales
$125.73 million
Book Value
$3.15 per share

Profitability

Net Income
$-51.50 million
Pretax Margin
-44.28%

Debt

Price-To-Earnings

Miscellaneous

Free Float
22,736,000
Market Cap
$547.53 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/03/2021
Today
11/27/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/23/2022

MarketRank

Overall MarketRank

2.32 out of 5 stars

Medical Sector

266th out of 1,391 stocks

Surgical & Medical Instruments Industry

26th out of 125 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












Vapotherm (NYSE:VAPO) Frequently Asked Questions

Is Vapotherm a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Vapotherm stock.
View analyst ratings for Vapotherm
or view top-rated stocks.

How has Vapotherm's stock been impacted by Coronavirus (COVID-19)?

Vapotherm's stock was trading at $7.79 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VAPO shares have increased by 169.6% and is now trading at $21.00.
View which stocks have been most impacted by COVID-19
.

When is Vapotherm's next earnings date?

Vapotherm is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Vapotherm
.

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) announced its earnings results on Wednesday, November, 3rd. The company reported ($0.52) earnings per share for the quarter, missing analysts' consensus estimates of ($0.50) by $0.02. Vapotherm had a negative trailing twelve-month return on equity of 54.76% and a negative net margin of 44.28%. During the same period in the prior year, the business posted ($0.49) EPS.
View Vapotherm's earnings history
.

What guidance has Vapotherm issued on next quarter's earnings?

Vapotherm issued an update on its FY 2021 earnings guidance on Wednesday, November, 17th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $106 M-, compared to the consensus revenue estimate of $102.68 million.

What price target have analysts set for VAPO?

3 equities research analysts have issued 1 year target prices for Vapotherm's stock. Their forecasts range from $36.00 to $45.00. On average, they anticipate Vapotherm's stock price to reach $40.33 in the next twelve months. This suggests a possible upside of 92.1% from the stock's current price.
View analysts' price targets for Vapotherm
or view top-rated stocks among Wall Street analysts.

Who are Vapotherm's key executives?

Vapotherm's management team includes the following people:
  • Joseph F. Army, President, Chief Executive Officer & Director
  • John Coolidge, Vice President-Operations
  • John Landry, CFO, Treasurer, VP & Chief Accounting Officer
  • George Dungun, Vice President-Science & Innovation
  • Richelle Helman, VP-Regulatory Affairs, Research & Development

What is Joe Army's approval rating as Vapotherm's CEO?

65 employees have rated Vapotherm CEO Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among Vapotherm's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Square (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and (APHA).

When did Vapotherm IPO?

(VAPO) raised $60 million in an initial public offering on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

Who are Vapotherm's major shareholders?

Vapotherm's stock is owned by a number of institutional and retail investors. Top institutional investors include Artisan Partners Limited Partnership (8.02%), BlackRock Inc. (6.47%), Geode Capital Management LLC (1.42%), New York State Common Retirement Fund (1.39%), Renaissance Technologies LLC (0.81%) and Balyasny Asset Management LLC (0.79%). Company insiders that own Vapotherm stock include 3X5 Partners, Llc, Anthony L Arnerich, Craig B Reynolds, Gregoire Ramade, James W Liken, Joel F Dube, John Landry, Marina Hahn, Prescott General Partners Llc and Thomas W Smith.
View institutional ownership trends for Vapotherm
.

Which institutional investors are selling Vapotherm stock?

VAPO stock was sold by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Artisan Partners Limited Partnership, Renaissance Technologies LLC, New York State Common Retirement Fund, Caption Management LLC, Two Sigma Advisers LP, Two Sigma Investments LP, and Squarepoint Ops LLC. Company insiders that have sold Vapotherm company stock in the last year include 3X5 Partners, Llc, Anthony L Arnerich, Gregoire Ramade, Joel F Dube, and John Landry.
View insider buying and selling activity for Vapotherm
or view top insider-selling stocks.

Which institutional investors are buying Vapotherm stock?

VAPO stock was acquired by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, Pier Capital LLC, Millennium Management LLC, Bayberry Capital Partners LP, Berman Capital Advisors LLC, BlackRock Inc., Goldman Sachs Group Inc., and Marshall Wace LLP. Company insiders that have bought Vapotherm stock in the last two years include James W Liken, Prescott General Partners Llc, and Thomas W Smith.
View insider buying and selling activity for Vapotherm
or or view top insider-buying stocks.

How do I buy shares of Vapotherm?

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $21.00.

How much money does Vapotherm make?

Vapotherm has a market capitalization of $547.53 million and generates $125.73 million in revenue each year. The company earns $-51.50 million in net income (profit) each year or ($2.26) on an earnings per share basis.

How many employees does Vapotherm have?

Vapotherm employs 401 workers across the globe.

What is Vapotherm's official website?

The official website for Vapotherm is www.vapotherm.com.

Where are Vapotherm's headquarters?

Vapotherm is headquartered at 100 DOMAIN DRIVE, EXETER NH, 03833.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at (603) 658-0011 or via email at [email protected].


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.